FindTrial
Sign In

Effects of remimazolam on emergence delirium in children undergoing tonsillectomy and adenoidectomy under general anesthesia

Remimazolam for the prevention of emergence delirium in children following tonsillectomy and adenoidectomy under sevoflurane anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054959
Enrollment
Unknown
Registered
2021-12-29
Start date
2022-01-02
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergence Delirium

Interventions

Intervention group:an intravenous injection of remimazolam 0.2mg/kg after surgery
Control group:an intravenous injection of equal volume of 0.9% saline postoperatively

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 1. ASA physical status I or II; 2. Aged 3-7 years; 3. scheduled for elective tonsillectomy and adenoidectomy

Exclusion criteria

Exclusion criteria: 1. Neuropsychiatric diseases; 2. Acute upper respiratory tract infection/recovery period; 3. Cardiopulmonary disease; 4. Developmental delay; 5. intake of any sedative drug before surgery

Design outcomes

Primary

MeasureTime frame
incidence of emergence delirium;—

Secondary

MeasureTime frame
emergence time;peak pediatric emergence delirium scores;pain intensity;length of PACU stay;parental satisfaction;postoperative behavioral changes;preoperative anxiety;—

Countries

China

Contacts

Public ContactYao Yusheng

Fujian Provincial Hospital

fjslyys@126.com+86 13559939629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026